Seventy percent of health plans surveyed rank provider AI tools among their top three cost drivers. Hospitals and health systems are investing large sums...
The approval and rollout of disease-modifying therapies for Alzheimer’s disease represent one of the most significant advances in neurology in decades. For the first...
